Odyssey Health (ODYY) EBT (QoQ) (2015 - 2026)
Odyssey Health (ODYY) EBT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -38.82% |
| Jan 31, 2026 | -49.14% |
| Oct 31, 2025 | -85.72% |
| Jul 31, 2025 | -12.67% |
| Apr 30, 2025 | 13.44% |
| Jan 31, 2025 | 66.06% |
| Oct 31, 2024 | -521.89% |
| Jul 31, 2024 | 132.37% |
| Apr 30, 2024 | 63.47% |
| Jan 31, 2024 | -141.41% |
| Oct 31, 2023 | 57.60% |
| Jul 31, 2023 | 1.16% |
| Apr 30, 2023 | 23.60% |
| Jan 31, 2023 | 21.80% |
| Oct 31, 2022 | -82.70% |
| Jul 31, 2022 | 62.05% |
| Apr 30, 2022 | -41.86% |
| Jan 31, 2022 | -32.71% |
| Oct 31, 2021 | 36.14% |
| Jul 31, 2021 | 79.30% |